GLUE vs BEAM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BEAM Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Beam Therapeutics Inc. Common Stock (BEAM) driven by superior Momentum & Technical, Options & Structure while GLUE counters with relative strength in Valuation, Growth & Margin. Fundamentally, GLUE trades at 10.0x Forward P/E with -214.5% operating margin (+325.8% YoY revenue) versus BEAM at N/M Forward P/E and -267.7% operating margin (-96.8% YoY). In options structure, GLUE sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against BEAM sits in BREAKDOWN (34th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | GLUE Revenue | BEAM Revenue | GLUE Op. Margin | BEAM Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $0M | N/A | -417522.2% | BEAM |
| FY2020 | N/A | $0M | N/A | -553166.7% | BEAM |
| FY2021 | N/A | $50M | N/A | -757.0% | BEAM |
| FY2022 | N/A | $60M | N/A | -555.6% | BEAM |
| FY2023 | N/A | $380M | N/A | -46.7% | BEAM |
| FY2024 | $80M | $60M | -107.3% | -654.3% | GLUE |
| FY2025 | $120M | $140M | -43.8% | -274.6% | GLUE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GLUE | BEAM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $761.4M | $2.2B | Larger Scale | BEAM |
| Trailing P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | GLUE |
| Forward P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | GLUE |
| Revenue Growth (YoY) Growth | +325.8% | -96.8% | Higher Growth | GLUE |
| Operating Margin (TTM) Profitability | -214.5% | -267.7% | Higher Margin | GLUE |
| Net Profit Margin Profitability | -186.2% | -73.9% | Higher Margin | BEAM |
| Return on Equity (ROE) Capital Efficiency | -35.3% | -11.3% | Higher ROE | BEAM |
| 52-Week Range Position Momentum | 1% ($8โ$26) | 4% ($20โ$38) | Stronger Trend | BEAM |
| Beta / 30D Volatility Risk Regime | 0.87ฮฒ ยท 45% Vol | 2.09ฮฒ ยท 86% Vol | Lower Realized Risk | GLUE |
| Unified Institutional Score Composite Signal | 40.6 / 100 (SELL) | 60.3 / 100 (BUY) | Higher Composite | BEAM |